﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/lupin-announces-closure-of-usfda-inspection-at-its-somerset-facility-with-zero-483-observations-16737</loc><lastmod>2025-02-03T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/curateq-biologics-receives-positive-opinion-for-biosimilar-dyrupeg-from-ema-16738</loc><lastmod>2025-02-03T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/jubilant-pharmova-q3-fy25-revenue-up-9-16739</loc><lastmod>2025-02-03T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/wockhardts-zaynich-achieves-highest-ever-efficacy-meeting-superiority-in-a-global-pivotal-registration-enabling-phase-iii-study-16740</loc><lastmod>2025-02-03T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/nectar-lifesciences-posts-q3-fy25-pat-at-rs-784-cr-16741</loc><lastmod>2025-02-03T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>